Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma	Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenoma, epithelial neoplasm, lung disorder, lung neoplasm, malignant mesothelioma, mesothelial neoplasm, mesothelioma, neoplasm, pleural neoplasm, respiratory system disorder, respiratory tract neoplasm	Not yet recruiting	Phase 1 / Phase 2	2025-08-20		NCT07131345

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Cancer Hospital of Zhengzhou University	1
Beijing Chest Hospital, Capital Medical University	11
National Cancer Center, China	11
Qilu Pharmaceutical Co., Ltd.	126
Shaanxi Provincial Cancer Hospital	2
The Affiliated Hospital of Inner Mongolia Medical University	19

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.